RSI Oversold Stocks
COO is flagged as RSI oversold, meaning recent selling pressure has pushed momentum to extreme levels that may lead to a short-term rebound.
COOPER COS INC/THE (COO) Stock Price & Overview
NASDAQ:COO • US2166485019
Current stock price
64.42 USD
-0.53 (-0.82%)
At close:
64.42 USD
0 (0%)
After Hours:
The current stock price of COO is 64.42 USD. Today COO is down by -0.82%. In the past month the price decreased by -9.95%. In the past year, price decreased by -20.36%.
COO Key Statistics
52-Week Range61.775 - 89.83
Current COO stock price positioned within its 52-week range.
1-Month Range63.715 - 72.63
Current COO stock price positioned within its 1-month range.
- Market Cap
- 12.569B
- P/E
- 14.95
- Fwd P/E
- 12.69
- EPS (TTM)
- 4.31
- Dividend Yield
- 0.02%
COO Stock Performance
Today
-0.82%
1 Week
-8.05%
1 Month
-9.95%
3 Months
-20.75%
Longer-term
6 Months -12.37%
1 Year -20.36%
2 Years -27.67%
3 Years -32.45%
5 Years -37.29%
10 Years +68.33%
COO Stock Chart
COO Stock Screens
COO currently appears in the following ChartMill screener lists.
COO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to COO. When comparing the yearly performance of all stocks, COO is a bad performer in the overall market: 86.12% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
COO Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to COO. COO scores excellent on profitability, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
COO Earnings
On March 5, 2026 COO reported an EPS of 1.1 and a revenue of 1.02B. The company beat EPS expectations (5.74% surprise) and missed revenue expectations (-1.24% surprise).
Next Earnings DateMay 27, 2026
Last Earnings DateMar 5, 2026
PeriodQ1 / 2026
EPS Reported$1.10
Revenue Reported1.024B
EPS Surprise 5.74%
Revenue Surprise -1.24%
COO Forecast & Estimates
25 analysts have analysed COO and the average price target is 92.93 USD. This implies a price increase of 44.25% is expected in the next year compared to the current price of 64.42.
For the next year, analysts expect an EPS growth of 12.98% and a revenue growth 5.72% for COO
Analysts
Analysts75.2
Price Target92.93 (44.26%)
EPS Next Y12.98%
Revenue Next Year5.72%
COO Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Supplies COO Financial Highlights
Over the last trailing twelve months COO reported a non-GAAP Earnings per Share(EPS) of 4.31. The EPS increased by 14.32% compared to the year before.
Income Statements
Revenue(TTM)4.15B
Net Income(TTM)401.40M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.67% | ||
| ROA | 3.23% | ||
| ROE | 4.8% | ||
| Debt/Equity | 0.3 |
Chartmill High Growth Momentum
EPS Q2Q%19.57%
Sales Q2Q%6.16%
EPS 1Y (TTM)14.32%
Revenue 1Y (TTM)5.68%
COO Ownership
Ownership
Inst Owners105.41%
Shares195.11M
Float193.90M
Ins Owners0.58%
Short Float %3.36%
Short Ratio3.27
COO Latest News, Press Relases and Analysis
19 hours ago - By: Chartmill
COO Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.84 | 60.732B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.46 | 13.656B | ||
| SOLV | SOLVENTUM CORP | 10.41 | 11.958B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.92 | 5.381B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.59 | 4.093B | ||
| ICUI | ICU MEDICAL INC | 15.09 | 3.113B | ||
| HAE | HAEMONETICS CORP/MASS | 11.31 | 2.771B | ||
| XRAY | DENTSPLY SIRONA INC | 8.16 | 2.377B | ||
| NEOG | NEOGEN CORP | 28.13 | 2.035B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.85 | 1.527B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.23B | ||
| AVNS | AVANOS MEDICAL INC | 24.15 | 1.149B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About COO
Company Profile
The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Company Info
IPO: 1983-01-21
COOPER COS INC/THE
6101 Bollinger Canyon Road, Suite 500
San Ramon CALIFORNIA 94583 US
CEO: Albert G. White III
Employees: 15000
Phone: 19254603600
COOPER COS INC/THE / COO FAQ
What does COOPER COS INC/THE do?
The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
What is the current price of COO stock?
The current stock price of COO is 64.42 USD. The price decreased by -0.82% in the last trading session.
Does COOPER COS INC/THE pay dividends?
COOPER COS INC/THE (COO) has a dividend yield of 0.02%. The yearly dividend amount is currently 0.
How is the ChartMill rating for COOPER COS INC/THE?
COO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is COOPER COS INC/THE (COO) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on COO.
Can you provide the ownership details for COO stock?
You can find the ownership structure of COOPER COS INC/THE (COO) on the Ownership tab.
What is the Short Interest ratio of COOPER COS INC/THE (COO) stock?
The outstanding short interest for COOPER COS INC/THE (COO) is 3.36% of its float.